Attached files
file | filename |
---|---|
EX-10.1 - EX-10.1 - Akebia Therapeutics, Inc. | akba-ex101_385.htm |
EX-99.1 - EX-99.1 - Akebia Therapeutics, Inc. | akba-ex991_859.htm |
EX-32.1 - EX-32.1 - Akebia Therapeutics, Inc. | akba-ex321_6.htm |
EX-31.2 - EX-31.2 - Akebia Therapeutics, Inc. | akba-ex312_8.htm |
EX-31.1 - EX-31.1 - Akebia Therapeutics, Inc. | akba-ex311_10.htm |
EX-23.1 - EX-23.1 - Akebia Therapeutics, Inc. | akba-ex231_7.htm |
EX-10.28 - EX-10.28 - Akebia Therapeutics, Inc. | akba-ex1028_386.htm |
EX-10.18 - EX-10.18 - Akebia Therapeutics, Inc. | akba-ex1018_316.htm |
EX-10.13 - EX-10.13 - Akebia Therapeutics, Inc. | akba-ex1013_315.htm |
EX-10.6 - EX-10.6 - Akebia Therapeutics, Inc. | akba-ex106_314.htm |
EX-4.5 - EX-4.5 - Akebia Therapeutics, Inc. | akba-ex45_1095.htm |
10-K - 10-K - Akebia Therapeutics, Inc. | akba-10k_20171231.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT |
||||||
|
|
|
|
|
|
|
Name |
|
|
Ownership Percentage |
|
|
Jurisdiction of Organization |
Akebia Therapeutics Securities Corporation |
|
|
100 |
% |
|
Massachusetts |
Akebia Europe Limited |
|
|
100 |
% |
|
Ireland |